Dr. Anas Younes MD Medical Oncologist

Dr. Anas Younes is a medical oncologist in Houston, Texas and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Damascus University Faculty of Medicine and has been in practice for 31 years. Dr. Younes accepts several types of health insurance, listed below. He is one of 129 doctors at University of Texas M.D. Anderson Cancer Center who specialize in Medical Oncology.

Are you Dr. Anas Younes? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: Hematologic

Clinical Interests: Hodgkin and non-Hodgkin lymphoma, Antineoplastic Agents, Hodgkin Disease, Disease-Free Survival, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols, Mantle-Cell Lymphoma, Recurrence, Maximum Tolerated Dose

Hospital Affiliation

University of Texas M.D. Anderson Cancer Center
Ranked #1 in Cancer

Education & Medical Training

SUNY Health Science Center at Brooklyn
Residency, Internal Medicine, 1989

Medical College of Ohio at Toledo
Residency, Anatomic and Clinical Pathology, 1985 - 1986

Memorial Sloan-Kettering Cancer Center
Fellowship, 1992

Damascus University Faculty of Medicine
Class of 1983

Certifications & Licensure

American Board of Pediatrics
Certified 21 years in Pediatrics

American Board of Pediatrics
Certified 8 years in Developmental-Behavioral Pediatrics

MA State Medical License
Active through 2014

FL State Medical License
Active through 2015

Publications & Presentations

Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy.
Gopal, A. K.,Bartlett, N. L.,Forero-Torres, A.,Younes, A.,Chen, R.,Friedberg, J. W.,Matous, J. V.,Shustov, A. R.,Smith, S. E.,Zain, J.,O'Meara, M. M.,Fanale, M. A.

The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
Oki, Y.,Chuang, H.,Chasen, B.,Jessop, A.,Pan, T.,Fanale, M.,Dabaja, B.,Fowler, N.,Romaguera, J.,Fayad, L.,Hagemeister, F.,Alma Rodriguez, M.,Neelapu, S.,Samaniego, F.,Kwak, L.,Younes, A.

Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
Oki, Y.,Westin, J. R.,Vega, F.,Chuang, H.,Fowler, N.,Neelapu, S.,Hagemeister, F. B.,McLaughlin, P.,Kwak, L. W.,Romaguera, J. E.,Fanale, M.,Younes, A.,Rodriguez, M. A.,Orlowski, R. Z.,Wang, M.,Ouzounian, S. T.,Samaniego, F.,Fayad, L.

See all 27 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • CIGNA Open Access
  • Great West PPO
  • Horizon BCBS Direct Access
  • Horizon BCBS HMO
  • Horizon BCBS POS
  • Horizon BCBS PPO
  • Humana ChoiceCare Network PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by



Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.